论文部分内容阅读
丹参(Salvia miltiorrhiza)的根具有活血化瘀功效,近年来广泛应用治疗冠心病、慢性肝炎和治疗牛皮藓等疾病。目前,临床上治疗冠心病的丹参有两种剂型。一种是注射用水溶性针剂,一种是脂溶性口服“舒心片”。我们研究了舒心片中的有效成分,并将其中的主要成分之一的丹参酮Ⅱ-A,做成水可以溶解的丹参酮Ⅱ-A磺酸钠水针剂,这一新药已由上海第一制药厂正式生产。丹参根中除含有丹参酮Ⅱ-A,还有丹参酮
The root of salvia miltiorrhiza has the effect of promoting blood circulation and removing blood stasis. In recent years, it has been widely used in the treatment of coronary heart disease, chronic hepatitis and treatment of psoriasis and other diseases. At present, there are two dosage forms of Salvia miltiorrhiza in clinical treatment of coronary heart disease. One is a water-soluble injection for injection, and the other is a fat-soluble oral “Shuxin Tablet”. We studied the active ingredients in Shuxin tablets, and made one of the main components of tanshinone II-A into a water-soluble tanshinone II-A sodium sulphate aqueous injection. This new drug has been established by Shanghai No. 1 Pharmaceutical Factory. Official production. Salvia root contains tanshinone II-A in addition to tanshinone